ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma

Huang, Yinghui; Huang, Huiqian; Wang, Yong; Liu, Hui*; Huang, Yingdan*华中科技大学; 南昌大学; 1
Biology-Basel2022-2DOI: 10.3390/biology11020231
2被引14阅读
引用收藏
分享

摘要

Globally, colon adenocarcinoma (COAD) is one of the most frequent types of malignant tumors. About 40--50% of patients with advanced colon adenocarcinoma die from recurrence and metastasis. Long non-coding RNAs (lncRNAs) and 5-methylcytosine (5mC) regulatory genes have been demonstrated to involve in the progression and prognosis of COAD. The goal of this study was to explore the biological characteristics and potential predictive value of 5mC-related lncRNA signature in COAD. In this research, The Cancer Genome Atlas (TCGA) was utilized to obtain the expression of genes and somatic mutations in COAD, and Pearson correlation analysis was used to select lncRNAs involved in 5mC-regulated genes. Furthermore, we applied univariate Cox regression and Lasso Cox regression to construct 5mC-related lncRNA signature. Then Kaplan-Meier survival analysis, principal components analysis (PCA), receiver operating characteristic (ROC) curve, and a nomogram were performed to estimate the prognostic effect of the risk signature. GSEA was utilized to predict downstream access of the risk signature. Finally, the immune characteristics and immunotherapeutic signatures targeting this risk signature were analyzed. In the results, we obtained 1652 5mC-related lncRNAs by Pearson correlation analysis in the TCGA database. Next, we selected a risk signature that comprised 4 5mC-related lncRNAs by univariate and Lasso Cox regression. The prognostic value of the risk signature was proven. Finally, the biological mechanism and potential immunotherapeutic response of the risk signature were identified. Collectively, we constructed the 5mC-related lncRNA risk signature, which could provide a novel prognostic prediction of COAD patients.

学科与关键词

关键词
5-methylcytosinecolon adenocarcinomalncRNA signatureprognosisimmunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biology-Basel
发表日期
2022-02
卷期
第 11 卷, 第 2 期
页码
231
DOI
10.3390/biology11020231
期刊等级
3区
成果收录
SCIE
资助标注
Collaborative Innovation Center for Informatization and Balanced Development of K-12 Education by MOE and Hubei Province [xtzd2021-013]; Graduate Student Innovation Special Fund Project of Jiangxi Province [YC2021-B039]

作者

  • H

    Huang, Yinghui (第一作者)

  • H

    Huang, Huiqian

    cent china normal univ

查看全部 5 位作者收起作者
  • W

    Wang, Yong

    1 · nanchang univ

  • L

    Liu, Hui (通讯)

    cent china normal univ

  • H

    Huang, Yingdan (通讯)

    huazhong univ sci & technol · hubei canc hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417